DEMİRBÜGEN ÖZ, M. Et Al. 2020. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients. PHARMACOGENOMICS JOURNAL , vol.20, no.3 , 443-450.

DEMİRBÜGEN ÖZ, M., BASKAK, B., UÇKUN, Z., Artun, N. Y., Ozdemir, H., Ozel, T. K., ... ÖZGÜVEN, H.(2020). Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients. PHARMACOGENOMICS JOURNAL , vol.20, no.3, 443-450.

DEMİRBÜGEN ÖZ, MERVE Et Al. "Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients," PHARMACOGENOMICS JOURNAL , vol.20, no.3, 443-450, 2020

DEMİRBÜGEN ÖZ, MERVE D. Et Al. "Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients." PHARMACOGENOMICS JOURNAL , vol.20, no.3, pp.443-450, 2020

DEMİRBÜGEN ÖZ, M. Et Al. (2020) . "Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients." PHARMACOGENOMICS JOURNAL , vol.20, no.3, pp.443-450.

@article{article, author={MERVE DEMİRBÜGEN ÖZ Et Al. }, title={Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients}, journal={PHARMACOGENOMICS JOURNAL}, year=2020, pages={443-450} }